BNT162b2 vaccine not only targets COVID-19 virus, but may also help reduce and control innate inflammation

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended primary target. In a study recently published in the Clinical Immunology journal, researchers found that the vaccine not only targeted the COVID-19 virus, it also unexpectedly helped to reduce and control innate inflammation of other bacterial and fungal pathogens not related to the vaccine target.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup